CT of the Head
JJ · Effective Oct 1, 2015
60 active Medicare policies list G12.21, and 22 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
22 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Showing 10 of 14 · All Aetna policies
| Policy | Effective | Status of G12.21 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Analysis of Volatile Organic Compounds | Oct 3, 2023 | Covered |
| Antibody Tests for Neurologic Diseases | Feb 15, 2024 | Covered |
| Antineoplaston Therapy | Nov 21, 2023 | Covered |
| Attended Electroencephalographic (EEG) Video Monitoring | Apr 28, 2023 | Covered |
| Bathroom and Toilet Equipment and Supplies | Feb 16, 2024 |
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2025
National · Effective May 7, 2026
J5 · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
JL · Effective Jan 1, 2026
National · Effective Oct 1, 2026
National · Effective Jan 1, 2026
JL · Effective Oct 1, 2025
National · Effective Nov 6, 2025
National · Effective Aug 6, 2026
J6 · Effective Apr 1, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 2, 2025
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2025
National · Effective Oct 1, 2025
| Covered |
| Evoked Potential Studies | Oct 25, 2023 | Covered |
|---|
| Genetic Testing | Feb 27, 2024 | Covered |
|---|
| Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications | Aug 31, 2023 | Covered |
|---|
| Motor Cortex Stimulation | Oct 6, 2023 | Covered |
|---|
| Policy | Effective | Status of G12.21 |
|---|---|---|
| Airway Clearance Devices | Mar 1, 2026 | Covered |
| Edaravone | May 1, 2026 | Covered |
| Qalsody (Tofersen) | May 1, 2026 | Covered |
| Policy | Effective | Status of G12.21 |
|---|---|---|
| Concert Genetic Testing: Neurology | Not recorded | Referenced |
| Pulmonary Function Testing | Not recorded | Covered |
| Policy | Effective | Status of G12.21 |
|---|---|---|
| Airway Clearance Devices in the Ambulatory Setting | Nov 9, 2025 | Covered |
| Electrodiagnostic Testing (EMG/NCV) | Sep 15, 2026 | Covered |
| Policy | Effective | Status of G12.21 |
|---|---|---|
| Therapeutic use of Stem Cells, Blood and Bone Marrow Products | Oct 1, 2026 | Not covered |